Cash Flow Rigel Pharmaceuticals, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
18.00
-25.00
-58.00
-17.00
-29.00
-66.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
0.00
9.00
-29.00
9.00
-30.00
16.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
31.00
-5.00
-73.00
5.00
-52.00
-41.00
Cash Flow from Investing Activities
4.00
-4.00
72.00
-80.00
47.00
-23.00
Cash Flow from Financing Activities
-11.00
18.00
6.00
62.00
12.00
11.00
Net Cash Inflow / Outflow
23.00
8.00
5.00
-11.00
7.00
-53.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Rigel Pharmaceuticals, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
18.366
-28.980000000055
46.00
163.37%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
0.153
1.91600000000364
-1.00
-92.01%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
31.471
-21.9630000000417
52.00
243.29%
Cash Flow from Investing Activities
4.13
-0.330000000000627
4.00
1351.52%
Cash Flow from Financing Activities
-11.641
32.4160000000616
-43.00
-135.91%
Net Cash Inflow / Outflow
23.96
10.1230000000192
13.00
136.69%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 647.99% vs 92.21% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
31.47
-5.74
647.99%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
